Further, pathologic expression in tumours include renal cell, gastric, colorectal, breast, and thyroid cancers [5], with a substantial correlation between PSMA and vascular endothelial growth factor having been observed, indicating the potential of PSMA as a marker of angiogenesis [6]. Here, FOLH1 is linked to thyroid cancer.